Imagen de Portada

Potential Bias Models With Bayesian Shrinkage Priors for Dynamic Borrowing of Multiple Historical Control Data

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Tomohiro Ohigashi, Kazushi Maruo, Takashi Sozu, Ryo Sawamoto, Masahiko Gosho
Formato:	Artículo Open Access
Publicado:	Wiley 2024
Materias:	Pharmaceutical Statistics
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Nonparametric Bayesian approach for dynamic borrowing of historical control data
por: Ohigashi, Tomohiro, et al.
Publicado: (2024)

A Bayesian Hybrid Design With Borrowing From Historical Study
por: Zhaohua Lu, et al.
Publicado: (2024)

Approximate Bayesian Analysis for Borrowing External Controls for Randomized Controlled Trials With Dynamic Borrowing and Covariate Balancing Adjustment
por: Jixian Wang, et al.
Publicado: (2025)

Prospectively Specified Adaptive Bayesian Borrowing: Considerations, Methodologies, and Implementations
por: Saurabh Mukhopadhyay, et al.
Publicado: (2025)

Posterior Quantification of Borrowing from Multiple Historical Control Data in Bayesian Dynamic Borrowing Methods: A Scoping Review
por: Ohigashi, Tomohiro, et al.
Publicado: (2026)

A Commensurate Prior Model With Random Effects for Survival and Competing Risk Outcomes to Accommodate Historical Controls
por: Manoj Khanal, et al.
Publicado: (2025)

BOIN ‐ MEM : A Two‐Stage Design for Dose Optimization With Information Borrowing Across Dose Levels and Stages in Oncology Phase I/ II Trials
por: Ryo Kitabayashi, et al.
Publicado: (2025)

Control of Unconditional Type I Error in Clinical Trials With External Control Borrowing—A Two‐Stage Adaptive Design Perspective
por: Ping Gao, et al.
Publicado: (2025)

Prediction Intervals for Overdispersed Binomial Endpoints and Their Application to Toxicological Historical Control Data
por: Max Menssen, et al.
Publicado: (2025)

Shrinkage priors for isotonic probability vectors and binary data modeling, with applications to dose–response modeling
por: Philip S. Boonstra, et al.
Publicado: (2024)

Informing the Borrowing Process for Dose‐Finding Trials by Estimating the Similarity Between Population‐Specific Dose‐Toxicity Curves
por: Dario Zocholl, et al.
Publicado: (2025)

Bayesian Hierarchical Models for Subgroup Analysis
por: Yun Wang, et al.
Publicado: (2024)

A Bayesian Dynamic Model‐Based Adaptive Design for Oncology Dose Optimization in Phase I/II Clinical Trials
por: Yingjie Qiu, et al.
Publicado: (2024)

Multiple Comparisons With Overdispersed Multinomial Data: Methods, Properties and Application
por: Sören Budig, et al.
Publicado: (2026)

Simultaneous Inference Using Multiple Marginal Models
por: Ludwig A. Hothorn, et al.
Publicado: (2024)

Applying Bias Correction Methods to Build Hybrid Controls Using Real‐World Patients for a Phase IIb Randomized Controlled Trial of Baricitinib for Rheumatoid Arthritis
por: Heather J. Litman, et al.
Publicado: (2025)

Using Propensity Score Weighting to Enhance the Operating Characteristics of Power Prior in Leveraging External Data to Augment a Traditional Clinical Study
por: Heng Li, et al.
Publicado: (2025)

A Tipping Point Method to Evaluate Sensitivity to Potential Violations in Missing Data Assumptions
por: Cesar Torres, et al.
Publicado: (2025)

A Bayesian method to detect drug‐drug interaction using external information for spontaneous reporting system
por: Keisuke Tada, et al.
Publicado: (2024)

Simulation‐Based Bayesian Predictive Probability of Success for Interim Monitoring of Clinical Trials With Competing Event Data: Two Case Studies
por: Chiara Micoli, et al.
Publicado: (2025)

Utility‐Based Dose Optimization Approaches for Multiple‐Dose Randomized Trial Designs Accounting for Multiple Endpoints
por: Gina D'Angelo, et al.
Publicado: (2025)

Methodological Approaches for the Estimation of Confidence Intervals on Partial Youden Index Under Verification Bias
por: Sihan Jia, et al.
Publicado: (2026)

Sample Size Estimation Using a Partially Clustered Frailty Model for Biomarker‐Strategy Designs With Multiple Treatments
por: Derek Dinart, et al.
Publicado: (2024)

Bayesian Methods for Quality Tolerance Limit (QTL) Monitoring
por: J. C. Poythress, et al.
Publicado: (2024)

A Dose‐Finding Design for Drug Combinations Using a Bayesian 4 Parameter Logistic Model With Penalised D‐Optimality
por: Maxine Ajimi, et al.
Publicado: (2026)

Bayesian Solutions for Assessing Differential Effects in Biomarker Positive and Negative Subgroups
por: Dan Jackson, et al.
Publicado: (2024)

Multiplicity Adjustment Methods for a Three‐Way Crossover Bioequivalence Study
por: David Hinds, et al.
Publicado: (2026)

Multiple Comparisons Procedures for Analyses of Joint Primary Endpoints and Secondary Endpoints
por: Xiaolong Luo, et al.
Publicado: (2025)

Adaptive Constrained Weighted Estimation for Incorporating Multiple External Information Sources
por: Keita Takahashi, et al.
Publicado: (2025)

Personalized Treatment Selection for Multivariate Ordinal Scale Outcomes and Multiple Treatments
por: Chathura Siriwardhana, et al.
Publicado: (2025)

On the relative conservativeness of Bayesian logistic regression method in oncology dose‐finding studies
por: Cheng‐Han Yang, et al.
Publicado: (2024)

Predictive Ppk calculations for biologics and vaccines using a Bayesian approach – a tutorial
por: Jos Weusten, et al.
Publicado: (2024)

Designing and Evaluating Bayesian Advanced Adaptive Randomised Clinical Trials: A Practical Guide
por: Anders Granholm, et al.
Publicado: (2025)

Comparing various Bayesian random‐effects models for pooling randomized controlled trials with rare events
por: Minghong Yao, et al.
Publicado: (2024)

Bayesian Response Adaptive Randomization for Randomized Clinical Trials With Continuous Outcomes: The Role of Covariate Adjustment
por: Vahan Aslanyan, et al.
Publicado: (2024)

Digital twins and Bayesian dynamic borrowing: Two recent approaches for incorporating historical control data
por: Carl‐Fredrik Burman, et al.
Publicado: (2024)

Drift Parameter Based Sample Size Determination in Multi‐Stage Bayesian Randomized Clinical Trials
por: Yueyang Han, et al.
Publicado: (2025)

Real Effect or Bias? Good Practices for Evaluating the Robustness of Evidence From Comparative Observational Studies Through Quantitative Sensitivity Analysis for Unmeasured Confounding
por: Douglas Faries, et al.
Publicado: (2024)

Estimation of Treatment Policy Estimands for Continuous Outcomes Using Off‐Treatment Sequential Multiple Imputation
por: Thomas Drury, et al.
Publicado: (2024)

Bayesian Power‐Based Sample Size Determination for Single‐Arm Clinical Trials With Time‐to‐Event Endpoints
por: Go Horiguchi, et al.
Publicado: (2026)